Biotech Values

[oc631]

Half a backbone



If PSI-7977/938 proves safe (the efficacy and resistance profile shouldn't be in question IMO) it stands to be the backbone for the next generation of SOC. All single nuke competitors like IDX-184 and INX-189 will need to go back to the lab to develop a pyrimidine nuke to compete. Single HCV nukes may become outdated after the results of this trial.